Stocks
Invest in Stocks
Invest in stocks, ETFs, IPOs with fast orders. Track returns on your stock holdings and view real-time P&L on your positions.
F&O
Create Stock SIPAutomate your investments in this
Performance
Open
2,587.00Prev. Close
2,587.90Volume
35,075Total traded value
8.97 CrUpper Circuit
3,105.40Lower Circuit
2,070.40Fundamentals
| Market Cap | ₹43,885Cr |
| ROE | 55.94% |
| P/E Ratio(TTM) | 45.94 |
| EPS(TTM) | 56.39 |
| P/B Ratio | 25.70 |
| Dividend Yield | 2.08% |
| Industry P/E | 33.42 |
| Book Value | 100.80 |
| Debt to Equity | 0.02 |
| Face Value | 10 |
Understand Fundamentals
Financials
About GSK Pharma
GlaxoSmithKline is a leading biopharmaceutical company in India, committed to delivering innovative medicines and vaccines that improve the quality of life for millions in the country. Its core purpose is to unite science, technology, and talent, enabling the company to get ahead of disease and deliver impact together for patients. During the 2024-25 financial year, the company successfully served approximately 230 million patients throughout India.;
| Parent Organisation | GlaxoSmithKline Pharmaceuticals Limited |
| Managing Director | Mr. Bhushan Akshikar |
| NSE Symbol | GLAXO |
Shareholding Pattern
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Top Mutual Funds Invested(4)
Similar Stocks
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Abbott India | NA (0.00%) | 40.56 | ||
| Pfizer | NA (0.00%) | 28.69 | ||
| Astrazeneca Pharma India | NA (0.00%) | 123.79 | ||
| Sanofi Consumer Healthcare India | NA (0.00%) | 53.48 |